Skip to content

All Research Preprints

281-300 of 579 ARTICLES
https://doi.org/10.12688/verixiv.1865.1
Research Article metrics
T cell – macrophage interactions in tuberculosis as barriers to vaccine-induced immunity: What we’ve got here is failure to communicate
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 22 Sep 2025
https://doi.org/10.12688/verixiv.2077.1
Research Article metrics
Compatibility and stability of a Shigella polysaccharide-protein conjugate antigen formulated with aluminum-salt and CpG 1018® adjuvants
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 22 Sep 2025
https://doi.org/10.12688/verixiv.1752.2
Open Letter metrics
Revised
WHO preferred product characteristics for bivalent Salmonella Typhi/Paratyphi A vaccine for comprehensive protection against enteric fever– key considerations and research gaps
[version 2; peer review: 2 approved]
Peer Reviewers Yanguang Cong; Syed Luqman Ali
  • Funder
  • Gates Foundation
LATEST VERSION PUBLISHED 22 Sep 2025
https://doi.org/10.12688/verixiv.2085.1
Research Article metrics
Distribution of Rotavirus Alphagastroenteritidis Strains in Blantyre, Malawi During and After COVID-19 Pandemic
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 22 Sep 2025
https://doi.org/10.12688/verixiv.2086.1
Study Protocol metrics
Community-led Strategies for Ameliorating Antimicrobial Resistance in Nigeria:  Research Protocol for a Participatory Action Research Project
[version 1]
Peer Reviewers Invited
  • Funders
  • Gates Foundation
  • Robert Koch Institute's project 'Capacity Building in Applied Public Health Research in GHPP partner countries - CARE' from funds of the Federal Ministry of Health
PUBLISHED 22 Sep 2025
https://doi.org/10.12688/verixiv.2042.1
Research Article metrics
Feasibility of accelerating prevention of small vulnerable newborn births in Bangladesh: A mixed-methods study
[version 1]
Peer Reviewers Invited
  • Funders
  • Children’s Investment Fund Foundation
  • Gates Foundation
PUBLISHED 22 Sep 2025
https://doi.org/10.12688/verixiv.1743.1
Research Article metrics
Understanding Clients’ and Providers’ Perspectives on the Implementation of DMPA-SC for Self-injection Programming in Nigeria
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 19 Sep 2025
https://doi.org/10.12688/verixiv.2029.1
Research Article metrics
Understanding Barriers to HIV testing Among Pregnant women in Soweto, Johannesburg: A Socio-Ecological Perspective
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 19 Sep 2025
https://doi.org/10.12688/verixiv.2024.1
Research Article metrics
Gestational Week 13 – a Critical Window for Pre-Eclampsia Pathogenesis: A Cell-Free RNA Gene Expression Study
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 19 Sep 2025
https://doi.org/10.12688/verixiv.2051.1
Research Article metrics
Discovery and Optimization of First-in-Class Furopyrimidine-based Inhibitors of Henipaviruses
[version 1]
Peer Reviewers Invited
  • Funders
  • National Institute of Allergy and Infectious Diseases
  • Gates Foundation
PUBLISHED 19 Sep 2025
https://doi.org/10.12688/verixiv.1975.1
Research Article metrics
Relationship between IL-17A and pneumococcal carriage in children aged under two years: data from a randomised controlled trial in Vietnam
[version 1]
Peer Reviewers Invited
  • Funders
  • National Health and Medical Research Council
  • Gates Foundation
PUBLISHED 18 Sep 2025
https://doi.org/10.12688/verixiv.2031.1
Research Article metrics
Cost-effectiveness of human papillomavirus vaccination in Jordan: a modelling study
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 18 Sep 2025
https://doi.org/10.12688/verixiv.2010.1
Research Article metrics
Maternal screening coverage and determinants during facility-based antenatal care in Nigeria: Analysis of the 2018 Demographic and Health Survey
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 15 Sep 2025
https://doi.org/10.12688/verixiv.1999.1
Research Article metrics
Assessing Australia’s allocation of climate adaptation aid
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 15 Sep 2025
https://doi.org/10.12688/verixiv.2037.1
Research Article metrics
Improving maternal health service use among underserved pregnant women through social mechanisms: Evaluation of a quasi-experimental study in rural Ethiopia
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 15 Sep 2025
https://doi.org/10.12688/verixiv.1853.1
Research Article metrics
Using Low-Tech, Behaviorally Informed Solutions to Improve Teacher Adoption of Foundational Pedagogical Practices: Evidence from a Field Experiment in India
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 15 Sep 2025
https://doi.org/10.12688/verixiv.1993.1
Systematic Review metrics
Burden of antimicrobial resistance in culture-confirmed Salmonella Typhi isolates in India from 1977 to 2024: A systematic review and meta-analysis
[version 1]
Peer Reviewers Invited
  • Funders
  • World-leading Innovative & Smart Education (WISE), Nagasaki University
  • Japan Agency for Medical Research and Development
  • Gates Foundation
PUBLISHED 10 Sep 2025
https://doi.org/10.12688/verixiv.2006.1
Systematic Review metrics
Measuring multi-sector nutrition and health intervention coverage using composite coverage analysis methods: A scoping review
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 10 Sep 2025
https://doi.org/10.12688/verixiv.2040.1
Open Letter metrics
Stakeholder Views on Lessons Learned for the Antimicrobial Resistance Panel from Previous International Science Panels
[version 1]
Peer Reviewers Invited
  • Funders
  • Boston University
  • US National Academy of Medicine
  • Nigerian Academy of Science
  • Wellcome Trust
  • Gates Foundation
PUBLISHED 10 Sep 2025
https://doi.org/10.12688/verixiv.2019.1
Research Article metrics
Structural and Functional Impact of the G340S Mutation in Plasmodium falciparum Ferredoxin NADP⁺ Reductase: In silico Analysis and Molecular Docking
[version 1; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Nkechukwu Ikegbunam Moses; Kanika Verma
  • Funder
  • Gates Foundation
PUBLISHED 10 Sep 2025
281-300 of 579 ARTICLES

Stay Informed

Sign up for information about developments, publishing and publications from VeriXiv.

You must provide your first name
You must provide your last name
You must provide a valid email address
You must provide an institution.

Thank you!

We'll keep you updated on any major new updates to VeriXiv

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.